Join Thermo Fisher Scientific at EA4HP 2024

Attending the European Association for Haematopathology (EA4HP) meeting in Dubrovnik, Croatia?

At Thermo Fisher Scientific, we are helping to advance haemato-oncology research by developing innovative and advanced molecular testing solutions.

Join our symposium at EA4HP to hear a panel of experts share their insights on NGS for lymphoid malignancy research and how the Ion AmpliSeq Liverpool Lymphoid Network Panel can provide fast and comprehensive results for accurate characterization.

Join our upcoming symposium

Advances in NGS for Lymphoid Malignancies

Date: Sept 23, 2024
Time: 17.15h – 18.15h CEST

> View Program

> Add Calendar Reminder

Lymphoid disorders are heterogeneous and complex, making them challenging to analyze. There are a growing number of relevant biomarkers enabling a more complete and accurate characterization. Next-generation sequencing (NGS) is emerging as an important technique for simplifying lymphoid testing due to its ability to assess multiple genetic variants in a single test.

In this symposium, Dr. Campo will begin by introducing the role of NGS for lymphoid malignancies. Next, Dr. Menon will discuss the Liverpool Lymphoid Network, a community network of laboratories dedicated to advancing lymphoid molecular testing, and explain the comprehensive design of the new Ion AmpliSeq Liverpool Lymphoid Network Panel.

Lastly, Dr. Frigola will share his experience using the Liverpool Lymphoid Network Panel and provide compelling analytical data from his lab to demonstrate the value of NGS for lymphoid malignancy studies.

eahp24-campo

Dr. Elias Campo
Senior Consultant and Professor of Pathology,
Hospital Clinic Barcelona, University of Barcelona, IDIBAPS

eahp24-menon

Dr. Geetha Menon

Clinical Director,
Cheshire & Merseyside Cancer Network, Liverpool Clinical Laboratories

eahp24-frigola

Dr. Gerard Frigola
Hematopathologist,
Hospital Clinic Barcelona, University of Barcelona, IDIBAPS

Featured Solutions

Oncomine Myeloid Assay GX v2

One of the only myeloid genomic profiling solution that can deliver an NGS report, covering key DNA and RNA targets, in as little as 24 hours on the Ion Torrent Genexus System. Learn More

Oncomine Pan-Clonality Assays

Advanced NGS solutions that can sequence multiple B- and T-cell receptor targets in a single reaction for highly sensitive and specific clone detection. Learn More

Ion AmpliSeq Liverpool Lymphoid Network Panel

Profile a range of lymphoid mutations in a single test in as little as 24 hours and access a community network of leading researchers.
Learn More

> Explore our full hemato-oncology research portfolio

Explore The Genexus System

Experience our new interactive virtual demo

One complete NGS system

The Ion Torrent™ Genexus™ System is a turnkey next-generation sequencing (NGS) solution that automates the end-to-end workflow from the biological specimen all the way to the final report and delivers results in as little as 24 hours.*

Thinking about how the Genexus System works and how it could fit into your lab?

In our virtual laboratory environment powered by augmented reality (AR) technology, you can see:

How the Ion Torrent™ Genexus™ Integrated Sequencer and Genexus™ Purification System fit into your space
Each step of the NGS workflow, including purification, sequencing, and analysis
Sample types and applications supported by the Genexus System